共 12 条
[1]
A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Hirschmann-Jax C,,Foster AE,Wulf GG,Nuchtern JG,Jax TW,Gobel U, et al. Proceedings of the National Academy of Sciences of the United States of America . 2004
[2]
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Wulf GG,Wang RY,Kuehnle I,et al. Blood . 2001
[3]
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Yoh K,Ishii G,Yokose T,et al. Clinical Cancer Research . 2004
[4]
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Kim M,Turnquist H,Jackson J,et al. Clinical Cancer Research . 2002
[5]
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Kondo T,Setoguchi T,Taga T. Proceedings of the National Academy of Sciences of the United States of America . 2004
[6]
Asurface glycoprotein modulating drug permea-bilityin Chinese hamster ovary cell mutants. Juliano RL,Ling V. Biochemica et Biophysica Acta . 1976
[7]
Characterization of the human ABCsuperfamily:isolation and mapping of21newgenes using the expressed sequence tags database. Allikmets R,Gerrard B,Hutchinson A,et al. Human Molecular Genetics . 1996
[8]
A multidrug resistance transporter fromhuman MCF-7breast cancer cells. Doyle LA,Yang W,Abruzzo LV,et al. Proceedings of the National Academy of Sciences of the United States of America . 1998
[9]
The human ATP- binding cassette(ABC) transporter super family. Dean M,Hamon Y,Chimini G. Journal of Lipid Research . 2001
[10]
A distinct"side population"of cellsin humantumor cells:implications for tumor bi-ology andtherapy. Hirschmann-Jax C,Foster AE,Wulf GG,et al. Cell Cycle . 2005